Kynam Capital Management
Latest statistics and disclosures from Kynam Capital Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001907884
Tip: Access up to 7 years of quarterly data
Positions held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Kynam Capital Management
Companies in the Kynam Capital Management portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Global Blood Therapeutics In (GBT) | 15.0 | $46M | 1.3M | 34.64 | ||
| Natera (NTRA) | 12.8 | $39M | 966k | 40.68 | ||
| Syndax Pharmaceuticals (SNDX) | 10.9 | $34M | 1.9M | 17.38 | ||
| Celldex Therapeutics Com New (CLDX) | 8.3 | $26M | 753k | 34.06 | ||
| Travere Therapeutics (TVTX) | 7.3 | $22M | 871k | 25.77 | ||
| Gossamer Bio (GOSS) | 5.2 | $16M | 1.8M | 8.68 | ||
| Xenon Pharmaceuticals (XENE) | 4.8 | $15M | 483k | 30.57 | ||
| Vaxcyte (PCVX) | 4.5 | $14M | 580k | 24.15 | ||
| Vera Therapeutics Cl A (VERA) | 3.8 | $12M | 502k | 23.49 | ||
| Miragen Therapeutics (VRDN) | 3.5 | $11M | 590k | 18.49 | ||
| Liquidia Corporation Com New (LQDA) | 2.7 | $8.3M | 1.2M | 7.18 | ||
| Biogen Idec (BIIB) | 2.6 | $8.1M | 38k | 210.61 | ||
| Amarin Corp Spons Adr New (AMRN) | 2.4 | $7.5M | 2.3M | 3.29 | ||
| Burning Rock Biotech Sponsored Ads (BNR) | 2.3 | $7.2M | 773k | 9.29 | ||
Setup an alertKynam Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Sierra Oncology Com New (SRRA) | 2.0 | $6.2M | 193k | 32.05 | ||
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.9 | $6.0M | 669k | 8.97 | ||
| Amicus Therapeutics (FOLD) | 1.8 | $5.4M | 574k | 9.47 | ||
| Wave Life Sciences SHS (WVE) | 1.2 | $3.8M | 1.9M | 2.00 | ||
| Fate Therapeutics (FATE) | 1.1 | $3.5M | 91k | 38.77 | ||
| Merus N V (MRUS) | 1.0 | $3.1M | 117k | 26.44 | ||
| Seres Therapeutics (MCRB) | 0.7 | $2.1M | 291k | 7.12 | ||
| Puma Biotechnology (PBYI) | 0.6 | $1.9M | 653k | 2.88 | ||
| Akouos (AKUS) | 0.6 | $1.8M | 388k | 4.75 | ||
| Radius Health Com New (RDUS) | 0.5 | $1.6M | 186k | 8.83 | ||
| Affimed Therapeutics B V (AFMD) | 0.5 | $1.5M | 348k | 4.37 | ||
| Cabaletta Bio (CABA) | 0.4 | $1.3M | 616k | 2.03 | ||
| Krystal Biotech (KRYS) | 0.4 | $1.2M | 18k | 66.55 | ||
| Olema Pharmaceuticals (OLMA) | 0.4 | $1.2M | 281k | 4.26 | ||
| Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $688k | 228k | 3.02 | ||
| Tg Therapeutics Put Option (TGTX) | 0.1 | $401k | 259k | 1.55 | ||
| Neoleukin Therapeutics (NLTX) | 0.1 | $264k | 141k | 1.88 | ||
| Nektar Therapeutics Put Option (NKTR) | 0.1 | $260k | 200k | 1.30 | ||
| Catalyst Biosciences Com New (CBIO) | 0.0 | $70k | 106k | 0.66 | ||
Past Filings by Kynam Capital Management
SEC 13F filings are viewable for Kynam Capital Management going back to 2022
- Kynam Capital Management 2022 Q1 filed May 13, 2022